Cargando…

Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study

BACKGROUND: DOPPS reported that thousands of life-years could be gained in the US and Europe over 5 years by correcting six modifiable haemodialysis practices. We estimated potential life-years gained across 10 European countries using MONITOR-CKD5 study data. METHODS: The DOPPS-based target ranges...

Descripción completa

Detalles Bibliográficos
Autores principales:	Combe, Christian, Mann, Johannes, Goldsmith, David, Dellanna, Frank, Zaoui, Philippe, London, Gérard, Denhaerynck, Kris, Krendyukov, Andriy, Abraham, Ivo, MacDonald, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402099/ https://www.ncbi.nlm.nih.gov/pubmed/30836953 http://dx.doi.org/10.1186/s12882-019-1251-z

Ejemplares similares

Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study
por: London, Gérard, et al.
Publicado: (2018)

Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study)
por: Gesualdo, Loreto, et al.
Publicado: (2015)

HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience
por: Dellanna, Frank, et al.
Publicado: (2017)

Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience?
por: Goldsmith, David, et al.
Publicado: (2018)

Japanese haemodialysis anaemia management practices and outcomes (1999–2006): results from the DOPPS
por: Akizawa, Tadao, et al.
Publicado: (2008)

Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS
por: Komaba, Hirotaka, et al.
Publicado: (2021)

Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained
por: Aapro, Matti, et al.
Publicado: (2018)

Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study
por: Bokemeyer, Carsten, et al.
Publicado: (2017)

The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study
por: Locatelli, Francesco, et al.
Publicado: (2014)

QT interval in CKD and haemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2013)

Estimating the Fraction of First-Year Hemodialysis Deaths Attributable to Potentially Modifiable Risk Factors: Results from the DOPPS
por: Karaboyas, Angelo, et al.
Publicado: (2020)

Mortality risk in patients on hemodiafiltration versus hemodialysis: a ‘real-world’ comparison from the DOPPS
por: Locatelli, Francesco, et al.
Publicado: (2018)

Development and 10-year history of a biosimilar: the example of Binocrit(®)
por: Aapro, Matti, et al.
Publicado: (2018)

Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim
por: Gascon, Pere, et al.
Publicado: (2019)

Haemoglobin concentration and survival of haemodialysis patients before and after experiencing cardiovascular disease: a cohort study from Japanese dialysis outcomes and practice pattern study (J-DOPPS)
por: Kido, Ryo, et al.
Publicado: (2019)

Thrombocytopenia predicts mortality in Chinese hemodialysis patients- an analysis of the China DOPPS
por: Zhao, Xinju, et al.
Publicado: (2022)

Facility Variation and Predictors of Do Not Resuscitate Orders of Hemodialysis Patients in Canada: DOPPS
por: Moorman, Danielle, et al.
Publicado: (2019)

Baseline data report of the China Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Zhao, Xinju, et al.
Publicado: (2021)

Ten-year experience of an outpatient clinic for CKD-5 patients with multidisciplinary team and educational support
por: Terlizzi, Vincenzo, et al.
Publicado: (2021)

Association between allopurinol and mortality among Japanese hemodialysis patients: results from the DOPPS
por: Tsuruta, Yuki, et al.
Publicado: (2014)

PET Imaging of Fatty Acid Amide Hydrolase with [(18)F]DOPP in Nonhuman Primates
por: Rotstein, Benjamin H., et al.
Publicado: (2014)

Understanding associations of hemodialysis practices with clinical and patient-reported outcomes: examples from the DOPPS
por: Port, Friedrich K., et al.
Publicado: (2017)

An ISN-DOPPS Survey of the Global Impact of the COVID-19 Pandemic on Peritoneal Dialysis Services
por: Albakr, Rehab, et al.
Publicado: (2022)

The first year on haemodialysis: a critical transition
por: Broers, Natascha J.H., et al.
Publicado: (2015)

Forty years on haemodialysis with the original arteriovenous fistula
por: Nicolai, Giulia Adriana, et al.
Publicado: (2012)

Early Access Provision for Innovative Medicinal Products in Oncology: Challenges and Opportunities
por: Krendyukov, Andriy
Publicado: (2020)

Innovative oncology products: time to revisit the strategy development?
por: Krendyukov, Andriy
Publicado: (2019)

The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda
por: Fliser, Danilo, et al.
Publicado: (2011)

Usefulness and feasibility of measuring ionized calcium in haemodialysis patients
por: Jean, Guillaume, et al.
Publicado: (2015)

Variability in total serum IgE over 1 year in severe asthmatics
por: Louis, Renaud, et al.
Publicado: (2019)

Extrapolation concept at work with biosimilar: a decade of experience in oncology
por: Krendyukov, Andriy, et al.
Publicado: (2018)

The ESMO position paper on biosimilars in oncology: enhancing the provision of accurate education and information
por: Schiestl, Martin, et al.
Publicado: (2017)

Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies
por: Krendyukov, Andriy, et al.
Publicado: (2019)

Pregnancy weight gain in twin gestations and maternal and child health outcomes at 5 years
por: Bodnar, Lisa M., et al.
Publicado: (2021)

Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)
por: Aapro, M., et al.
Publicado: (2016)

Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUS(TM) Study
por: Leys, Anita M, et al.
Publicado: (2020)

Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)
por: Van Aken, Elisabeth, et al.
Publicado: (2020)

Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion
por: Robinson, Bruce M., et al.
Publicado: (2021)

Serum Phosphorus Level Rises in US Hemodialysis Patients Over the Past Decade: A DOPPS Special Report
por: Guedes, Murilo, et al.
Publicado: (2022)

5‐Hydroxytryptophan toxicity successfully treated by haemodialysis in a dog
por: Arbona, Diana Victoria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b74g26ldnvjafljsp60oks757k